134
Participants
Start Date
April 12, 2022
Primary Completion Date
August 31, 2025
Study Completion Date
September 30, 2025
SRF388
SRF388 will be administered by intravenous injection (IV)
Atezolizumab
Azezolizumab will be administered by IV
Bevacizumab
Bevacizumab will be administered by IV
Placebo
Placebo will be administered by IV
Kaohsiung Medical University - Chung-Ho Memorial Hospital, Kaohsiung City
Buddhist Tzu Chi General Hospital - Hualien Tzu Chi Medical Center, Hualien City
The Alfred Hospital, Melbourne
National Taiwan University Hospital, Taipei
Veterans Affairs New York Harbor Healthcare System - Manhattan VA Medical Center, New York
NYU Langone Medical Center - Laura and Isaac Perlmutter Cancer Center (NYU Cancer Institute (NYUCI)), New York
Seoul National University Bundang Hospital, Seongnam
University of Florida Health Science Center - Gainesville, Gainesville
University of Miami, Sylvester Comprehensive Cancer Center, Miami
Sarah Cannon Research Institute - Tennessee Oncology, Nashville
Sarah Cannon Research Institute - Tennessee Oncology, Chattanooga
Louisville VA Medical Center - Robley Rex VA Medical Center, Louisville
China Medical University Hospital, Taichung
Veterans Affairs Ann Arbor Healthcare System, Ann Arbor
University of Michigan Health System (UMHS), Ann Arbor
Henry Ford Hospital, Detroit
Pusan National University Yangsan Hospital, Yangsan
Chonnam National University (CNU) - Chonnam National University Hwasun Hospital (CNUHH), Gwangju
University of Oklahoma Health Sciences Center - Stephenson Cancer Center, Oklahoma City
E-Da Cancer Hospital, Kaohsiung City
University of Arizona Cancer Center - North Campus, Tucson
University of Southern California - Norris Comprehensive Cancer Center, Los Angeles
City of Hope, Duarte
Providence Portland Medical Center, Portland
Royal Melbourne Hospital, Melbourne
The Catholic University of Korea - St. Vincent's Hospital, Suwon
Daegu Catholic University Medical Center (DCUMC), Daegu
Ajou University Hospital, Gyeonggi-do
CHA University - Bundang CHA General Hospital (CHA Bundang Medical Center), Gyeonggi-do
Severance Hospital, Seoul
Gangnam Severance Hospital - Cancer Hospital, Seoul
Korea University Medical Center - Korea University Anam Hospital, Seoul
University of Ulsan College of Medicine - Asan Medical Center (AMC), Seoul
Seoul National University Hospital (SNUH) - SMG-SNU Boramae Medical Center, Seoul
Lead Sponsor
Coherus Oncology, Inc.
INDUSTRY